Discovery on Target 2017 Faculty

Plenary Keynote Speaker: Jeffrey V. Ravetch, M.D., Ph.D., Professor and Head, Laboratory of Molecular Genetics & Immunology, The Rockefeller University

Plenary Keynote Speaker: Raymond J. Deshaies, Ph.D., Senior Vice President, Discovery Research, Amgen

Aaron Gitler, Ph.D., Associate Professor, Department of Genetics, Stanford University

Abhishek Saharia, Ph.D., Director, Product Management, Synthego

Abraham Rubinstein, Ph.D., Professor, Institute for Drug Research, The Hebrew University of Jerusalem School of Pharmacy

Adam Hutchings, Director, Dolon Ltd.

Adam Weinglass, Ph.D., Director, Screening & Compound Profiling, Merck & Co.

Adrian Whitty, Ph.D., Professor, Biochemistry, Boston University

Alan M. Mathiowetz, Ph.D., Director, Pfizer Worldwide Medicinal Chemistry – Cardiovascular and Metabolic Diseases

Alan P. Kozikowski, Ph.D., Professor, College of Pharmacy, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago; Founder, Actuate Therapeutics Inc.

Alberto Mantovani, M.D., Professor, Pathology, Humanitas University; Scientific Director, Istituto Clinico Humanitas

Alejandro Villagra, Ph.D., Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University

Alessio Ciulli, Ph.D., Professor, Chemical & Structural Biology, School of Life Sciences, University of Dundee

Alexander Statsyuk, Ph.D., Assistant Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston

Alexei Degterev, Ph.D., Associate Professor, Developmental, Molecular and Chemical Biology Department, Tufts University

Alexey Rak, Ph.D., Head of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D

Ali Ashkar, D.V.M., Ph.D., Professor, Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University

Amar Sawhney, Ph.D., Executive Chairman, Ocular Therapeutix

Amy Lee, Ph.D., Senior Director, In Vivo Pharmacology and Macro-Molecular Discovery, Arbutus Biopharma Corp.

Andreas M. Kogelnik, M.D., Ph.D., Director, Open Medicine Institute

Andrew Alt, Ph.D., Associate Director, Biology, Arvinas

Andrew Fensome, Ph.D., Principal Scientist, Medicinal Chemistry, Pfizer

Andrew Nixon, Ph.D., Vice President, Biotherapeutics Molecule Discovery, Boehringer Ingelheim

Andrew Tager, M.D., Associate Professor of Medicine, Harvard Medical School

Andrew Vaillant, Ph.D., CSO, Replicor

Anindya Bhattacharya, Ph.D., Scientific Director, Neuroscience Drug Discovery, Janssen R&D

Anne Douar, Ph.D., Project Director, GenSight Biologics

Annette Gilchrist, Ph.D., Professor, Pharmacology, Midwestern University

Antonio Rezusta, Professor, Section Head, Microbiology, Hospital Universitario Miguel Servet

Arun Shukla, Ph.D., Assistant Professor, Indian Institute of Technology, India

Arvind Rao, Ph.D., Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center

Bahram (Bob) Valamehr, Ph.D., MBA, Vice President, Cancer Immunotherapy, Fate Therapeutics, Inc.

Bart Staels, Ph.D., Co-Founder, GENFIT

Benedikt Kessler, Ph.D., Professor of Biochemistry and Life Science Mass Spectrometry, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

Benjamin Doranz, Ph.D., President and CEO, Integral Molecular

Berkley A. Lynch, Ph.D., Senior Director, CNS Research, Rodin Therapeutics

Bernard Vanhove, Ph.D., COO, OSE Immunotherapeutics

Bill Harriman, Ph.D., CSO, Crystal Bioscience

Bo Liang, Ph.D., President, R&D, IVIEW Therapeutics, Inc.

Bonnie Feldman, D.D.S., MBA, Digital Health Analyst and Chief Growth Officer, DrBonnie360

Bret Wallace, Ph.D., Scientist, Symberix, Inc.

Brian Cathers, Ph.D., Executive Director, Co-Leader & Head, Drug Discovery, Protein Homeostasis Thematic Center of Excellence, Celgene

Brian Gerstenberger, Ph.D., Principal Scientist, Medicinal Chemistry, Pfizer

Bruce D. Given, M.D., COO, Arrowhead Pharmaceuticals

Bruce Given, M.D., COO, Head of R&D, Arrowhead Pharmaceuticals

Bryan C. Fuchs, Ph.D., Assistant Professor of Surgery, Harvard Medical School

Bryan Smith, Ph.D., Senior Director of Biology, Deciphera Pharmaceuticals

Bryan Lafitte, Ph.D., Director, Discovery Pharmacology, Genomics Institute of the Novartis Research

Cameron Wheeler, Ph.D., Principal, Deerfield Management

Carola Ries, Ph.D., Head, Cancer Immunotherapy I, Pharma Research and Early Development (pRED), Roche Innovation Center Munich

Carrie R. Daniel-MacDougall, Ph.D., MPH, Assistant Professor, Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center

Catherine Hutchings, Ph.D., Independent Consultant, United Kingdom

Cen Xu, Ph.D., Scientific Director, Neuroscience Drug Discovery, Amgen

Chris Kitson, Ph.D., Principal Scientist, Fibrosis Biology Discovery, Bristol-Myers Squibb

Christine Bulawa, Ph.D., Senior Director, Rare Disease Research Unit, Pfizer

Christine Guntermann, Ph.D., Project Team Head, Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research

Christopher Harris, Ph.D., Associate Director, AbbVie

Christopher Negron, Ph.D., Senior Scientist, Schrödinger

Ciro Bonetti, Ph.D., Scientist, Regeneron Pharmaceuticals

Claudio Ciferri, Ph.D., Senior Scientist, Structural Biology, Genentech

Clifford Lingwood, Ph.D., Senior Scientist, Molecular Structure and Function, Hospital for Sick Children

Clifford Steer, M.D., Professor of Medicine and Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School

Craig M. Crews, Ph.D., Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology; Professor, Chemistry & Pharmacology, Yale University

Cyril Bařinka, Ph.D., Principal Investigator, Laboratory of Structural Biology, Institute of Biotechnology, Vestec, Czech Republic

Dan Peer, Ph.D., Director, Laboratory of Precision NanoMedicine, Tel Aviv University

Daniel Chung, D.O., Clinical Ophthalmic Lead, Sparks Therapeutics

Dara Burdette, Ph.D., Research Scientist II, Discovery Virology, Gilead Sciences

Dario A. Paggiarino, M.D., Vice President, CMO, pSivida

David Donabedian, Ph.D., Venture Partner, Longwood Fund; Chief Executive Officer and co-founder of Longwood portfolio Company Axial Biotherapeutics

David Ferguson, Ph.D., Professor, Medicinal Chemistry, University of Minnesota

David H. Raulet, Ph.D., C.H. Li Professor of Immunology and Pathogenesis; Co-Chair, Department of Molecular and Cell Biology, University of California, Berkeley

David J. Earp, J.D., Ph.D., President and CEO, Circle Pharma

David Liu, Ph.D., CSO and Head, R&D Protagonist Therapeutics

David M. Knipe, Ph.D., Higgins Professor and Interim Co-Chair, Department of Microbiology and Immunobiology, Harvard Medical School

David R. Tabatadze, Ph.D., President and CEO, ZATA Pharmaceuticals

Dawn Christianson, Ph.D., Senior Program Manager, Arrowhead Research Corporation

Dean Anthony Lee, M.D., Ph.D., Professor, Pediatrics; Director, Cellular Therapy and Cancer Immunotherapy Program, Nationwide Children’s Hospital; James Comprehensive Cancer Center/Solove Research Institute, The Ohio State University

Deepak Kumar Rajpal, Ph.D., Director, Computational Biology, GlaxoSmithKline

Derek Cole, Ph.D., Director, Medicinal Chemistry, Takeda

Dmitri Kireev, Ph.D., Professor, Chemical Biology & Medicinal Chemistry; Director, Computational Biophysics & Molecular Design, Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Domajog Vucic, Ph.D., Senior Scientist, Inflammation, Genentech

Donald Durden, M.D., Professor, Department of Pediatrics, University of California, San Diego; Director of Operations, SignalRx Pharmaceuticals

Doriano Fabbro, Ph.D., CSO, Piqur Therapeutics

Doug Treco, Ph.D., Director, President, CEO and Co-Founder, RA Pharma

Edward P. Feener, Ph.D., Co-Founder and CSO, KalVista Pharmaceuticals

Eileen White, Ph.D., CSO, Deputy Director & Associate Director, Basic Science, Rutgers Cancer Institute of New Jersey

Elias Reichel, M.D., Professor and Vice Chair, Tufts University School of Medicine; Director, Vitreoretinal Diseases and Surgery Service, New England Eye Center; Founder, Hemera Biosciences

Emmett Cunningham, Partner, Clarus Ventures

Eric H. Baehrecke, Ph.D., Professor, Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School

Eric Kmiec, Ph.D., Director, Gene Editing Program and Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System

Eric Lefebvre, M.D., Vice President, Head of Clinical Research and Development – NASH, Allergan

Eric Marsault, Ph.D., Professor, Department of Pharmacology-Physiology, Université de Sherbrooke

Eric Marsault, University of Sherbrooke

Eric. B. Kmiec, Ph.D., Director, Gene Editing Institute and Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System

Erik Henrich, Researcher, Institute of Biophysical Chemistry, University of Frankfurt, Germany

Fabien Vincent, Ph.D., Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer

Gang Yao, Ph.D., Senior Scientist, Encoded Library Technology Group Drug Design & Selection Boston, GSK

Garth Ringheim, Ph.D., Principal Investigator, Translational Development Inflammation and Immunology, Celgene Corporation

Geoffrey Bartholomeusz, Ph.D., Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Georg Gerber, M.D., Ph.D., MPH, FASCP, Assistant Professor of Pathology, Harvard Medical School; Member of the Faculty, Harvard-MIT Health Sciences & Technology; Co-Director, Massachusetts Host-Microbiome Center, and Director of the Computational Unit; Associate Pathologist, Center for Advanced Molecular Diagnostics; Department of Pathology, Brigham & Women's Hospital

George Cigale, Co-Founder & CEO, Mycrobiomics, Inc.

Georges Grinstein, Ph.D., Research Professor, Center for Data Science, College of Information and Computer Sciences, University of Massachusetts, Amherst MA and Consultant

Georgios Skiniotis, Ph.D., Professor, Molecular and Cellular Physiology and of Structural Biology, Stanford University Medical School

Gerald F. Cox, M.D., Ph.D., CMO, Editas Medicine

Gerald Gavory, Ph.D., Head, Biology, Alma Discovery

Geraldine Harriman, Ph.D., Founder and CSO, HotSpot Therapeutics, Inc.

Gerhard Mueller, Ph.D., CSO, Gotham Therapeutics

Gerry Higgins, Ph.D., M.D., Research Professor, Computational Medicine and Bioinformatics, University of Michigan Medical School

Glenn Noronha, Ph.D., CSO, Clearside Biomedical, Inc.

Greg Sieczkiewicz, J.D., Ph.D., Chief IP Counsel, MPM

Gregg Siegal, Ph.D., Lecturer, Faculty of Science, Leiden Institute of Chemistry, Leiden University

Gregory A. Michaud, Ph.D., Chemical Biology and Therapeutics (CBT), Novartis Institutes for BioMedical Research, Inc.

Guido J.R. Zaman, Ph.D., Managing Director & Head of Biology, Netherlands Translational Research Center B.V. (NTRC)

H. James Harwood Jr., Ph.D., Founder and CEO, Delphi BioMedical Consultants, LLC

Haiching Ma, CSO, Reaction Biology Corporation

Hans Klingemann, M.D., Ph.D., Vice President, Research & Development, NantKwest, Inc.

Hao Yin, Ph.D., Research Scientist, The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Helai Mohammad, Ph.D., Scientific Leader, Fellow, Cancer Epigenetics DPU, GlaxoSmithKline

Henk-Jan Joosten, Ph.D., CEO, Bio-Prodict

Hong I. Wan, Ph.D., Chief Scientific Officer, Alexo Therapeutics, Inc.

Huixian Wu, Ph.D., Senior Scientist, Groton Center of Chemistry, Pfizer

Iain Campuzano, Ph.D., Principal Scientist, Amgen

Imad Al Kassaa, Ph.D., Associate Professor, Microbiology, Lebanese University; Researcher, Laboratoire Microbiologie Sante et Environnement (LMSE)

Ingrid E. Wertz, M.D., Ph.D., Senior Scientist, Discovery Oncology and Early Discovery Biochemistry, Genentech, Inc.

Istvan Enyedy, Ph.D., Senior Scientist, Drug Discovery, Biogen

Ivan Zlatev, Ph.D., Senior Scientist, Research, Alnylam Pharmaceuticals

Ivana Vancurova, Ph.D., Professor of Biological Sciences, Department of Biology, Laboratory of Cancer Immunology, St. John’s University

Jack D. Scott, Ph.D., Principal Scientist, Merck

Jai Rautela, Ph.D., CSO & Co-Founder, oNKo-innate

James Brady, Vice President, Technical Applications & Customer Support, MaxCyte, Inc.

James Inglese, Ph.D., Director, Assay Development and Screening Technologies, National Center for Advancing Translational Sciences (NCATS), NIH

James Inglese, Ph.D., Head, Assay Development & Screening Technologies, National Center for Advancing Translational Sciences, NIH

Jan Spanholtz, Ph.D., CSO, Glycostem

Jane Seagal, Ph.D., Senior Scientist, Biologics Generation Group, AbbVie Bioresearch Center

Jason Brown, Ph.D., Scientific Director, Ubiquigent Ltd.

Jason Sheltzer, Ph.D., Principal Investigator, Cold Spring Harbor Laboratory

Jay S. Duker, M.D., Director, New England Eye Center; Professor and Chairman, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine; Founder, Hemera Biosciences

Jeff Hermes, Ph.D., Director, Chemical Biology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.

Jeff MacKeigan, Ph.D., Professor, College of Human Medicine, Michigan State University

Jeff Piotrowski, Ph.D., Principal Scientist, Target Identification, Yumanity Therapeutics

Jeffery Kutok, M.D., Ph.D., CSO, Biology and Translational Medicine, Infinity Pharmaceuticals

Jeffrey Barrett, Ph.D., Director, Open Targets and Group Leader, The Wellcome Trust Sanger Institute, Genome Research Limited

Jennifer Guerriero, Ph.D., Instructor of Medicine, Lead Scientist of the Immuno-Oncology Group, Letai Laboratory, Dana-Farber Cancer Institute

Jennifer Könitzer, Ph.D., Research Investigator, Immuno-Oncology Large Molecule Discovery, Bristol-Myers Squibb

Jennifer Smith, Ph.D., Assistant Director, ICCB-Longwood Screening Facility, Harvard Medical School

Jeremy R. Graff, Ph.D., CSO and Senior Vice President, Research, Biothera Pharmaceuticals, Inc.

Jessica Martinsson, Ph.D., Vice President, Medicinal Chemistry, Sprint Bioscience AB

Jianmin Gao, Ph.D., Associate Professor, Chemistry, Boston College

Joe Kovarik, J.D., Patent Attorney with Bioscience Focus and Shareholder, Sheridan Ross, P.C.

John M. Conley, J.D., Ph.D., William Rand Kenan, Jr. Professor of Law, University of North Carolina, Chapel Hill; Counsel, Robinson Bradshaw & Hinson

John Doench, Ph.D., Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT

John Feder, Ph.D., Associate Director of Genome Biology and Emerging Technologies, Department of Genetically Defined Diseases and Genomics, Bristol-Myers Squibb

John Hutchinson, Ph.D., President and CSO, PharmAkea

John Kenney, Ph.D., President, Antibody Solutions

John McCafferty, Ph.D., CEO, IONTAS, United Kingdom

John Robinson, Ph.D., Director, Medicinal Chemistry, Array Biopharma

John Wheeler, Principal Research Scientist, Janssen BioTherapeutics

Jonas Lee, Ph.D., Scientist, Membrane Protein Purification, Amgen

Jonathan Freeman, Chief Business Officer, Vedanta

Jonathan Gilbert, Ph.D., Director, Strategic Partnerships, SQZ Biotechnologies

Jonathan Gootenberg, Ph.D. Student, Laboratory of Dr. Feng Zhang, Broad Institute of MIT and Harvard

Jonathan Pachter, Ph.D., CSO, Translational Research, Verastem

Joseph Rucker, Ph.D., Vice President, Research and Development, Integral Molecular, Inc.

Joseph Wahle, Ph.D., Senior Scientist, Immunology and Respiratory Disease Research, Boehringer Ingelheim

Joshua Allen, Ph.D., Vice President, R&D, Oncoceutics

JT Koerber, Ph.D., Scientist, Antibody Engineering, Genentech

Julie Selkirk, Ph.D., Associate Director of Biology, Receptos/Celgene

Jun Sun, Ph.D., AGA Fellow, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago

Jung S. Huang, Ph.D., Professor, Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine

Kamal Puri, Ph.D., Director, Inflammation & Immunology, Celgene Corporation

Kamyar Hadian, Ph.D., Group Leader, Assay Development and Screening Platform, Helmholtz Zentrum Muenchen

Kamyar Hadian, Ph.D., Principal Investigator & Head, Assay Development and Screening Platform, HelmholtzZentrum München

Kanakaraju Kaliannan, M.D., Senior Research Fellow, Laboratory for Lipid Medicine and Technology (LLMT), Massachusetts General Hospital

Karl-Johan Malmberg, M.D., Ph.D., Professor, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital

Katherine Cygnar, Ph.D., Staff Scientist, Genome Engineering Tech, Regeneron Pharmaceuticals

Kathleen Elizabeth Corey, M.D., Assistant Professor of Medicine, Massachusetts General Hospital

Keith F. Batchelder, M.D., CEO and Founder, Genomic Healthcare Strategies

Kevin Lumb, Ph.D., Director, Discovery Sciences, Janssen R&D

Kevin S. Sweder, Ph.D., DABT, Director, The Forensic and National Security Sciences Institute, Center for Science & Technology, Syracuse University

Kipp A. Weiskopf, M.D., Ph.D., Resident Physician, Medicine, Brigham and Women's Hospital

Krishna Menon, Ph.D., Scientific Advisor, Research & Development, AR Biosystems 

Larry Weiss, CMO, AOBiome, LLC

Lata Jayaraman, Ph.D., Head, Tumor Immunotherapy, Seres Therapeutics

Laura Itzhaki, Ph.D., Professor, Department of Pharmacology, Cambridge University

Laura Silvian, Ph.D., Principal Scientist and Head, Physical Biochemistry, Biogen

Lauren Monovich, Ph.D., Senior Investigator, Global Discovery Chemistry, Novartis

Laurent Meijer, Ph.D., CEO & CSO, ManRos Therapeutics

Lawrence Dick, Ph.D., Director, Biochemistry, Oncology Drug Discovery Unit, Takeda Pharmaceuticals International Co.

Liaoyuan Hu, Ph.D., Scientific Director, Head of Pharmacology, Amgen Asia R&D Center

Linda Kaldenberg-Hendriks, Scientist, Merus, The Netherlands

Lisa Johnson, Ph.D., Research Scientist, Trillium Therapeutics, Inc.

Lisa Minor, Ph.D., Scientific Consultant, Multispan, Inc.

Luke Fisher, Ph.D., Principal Consultant, Collaborative Informatics, Collaborative Drug Discovery

Luke Robinson, Ph.D., Principal Scientist, Research, Visterra, Inc.

Lyn Jones, Ph.D., Vice President, Chemical Biology, Jnana Therapeutics

Malia B. Potts, Ph.D., Assistant Member, Cell and Molecular Biology, St. Jude Children’s Research Hospital

Marija Usenovic, Ph.D., Senior Scientist, Department of Neuroscience, Merck Research Laboratories, Merck & Co., Inc.

Mark L. Peterson, Ph.D., COO, Cyclenium Pharma, Inc.

Mark Schnute, Ph.D., Associate Research Fellow, Biotherapeutics Chemistry & Immunoscience Research, Pfizer Global R&D

Mark Smith, Ph.D., CEO, Finch Therapeutics

Martin Gustavsson, Ph.D., Post-Doctoral Scholar, Handel Lab, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego

Martin Treder, Ph.D., CSO, R&D, Affimed

Mary Harner, Ph.D., Research Investigator II, Mechanistic Biochemistry, Bristol-Myers Squibb R&D

Matthew E. Kennedy, Ph.D., Director, Neuroscience, Merck Research Labs

Matthew Eddy, Ph.D., Postdoctoral Fellow, Laboratory of Raymond Stevens, The Bridge Institute, University of Southern California

Matthew Eddy, Ph.D., Postdoctoral Fellow, Ray Stevens Laboratory, The Bridge Institute, University of Southern California

Matthieu Schapira, Ph.D., Principal Investigator, Structural Genomics Consortium, University of Toronto

Mehdi Gasmi, Ph.D., CTO & CSO, Adverum Biotechnologies

Menghang Xia, Ph.D., Leader, Systems Toxicology, Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, NIH

Mette M. Rosenkilde, M.D., Ph.D., Professor, Department of Biomedical Sciences, University of Copenhagen

Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University

Michael Blank, Ph.D., CSO, AptaIT GmbH

Michael Bradshaw, Ph.D., Associate Director, Principia Biopharma

Michael Burnet, Ph.D., Managing Director, Oncology Discovery, Synovo GmbH

Michael M. Goldberg, M.D., President and CEO, Navidea Biopharmaceuticals, Inc. & Macrophage Therapeutics, Inc.

Michael R. Green, Ph.D., Assistant Professor & Coordinator for Lymphoma Research, Eppley Institute for Research in Cancer and Allied Diseases and Member, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center

Michael Liebman, Ph.D., Managing Director, IPQ Analytics, LLC; Adjunct Professor of Pharmacology and Physiology, Drexel College of Medicine

Michael Nolan, Ph.D., Director, GlaxoSmithKline

Michael A. Walters, Ph.D., Director, Lead and Probe Discovery, ITDD (Institute for Therapeutics Discovery and Development); Research Associate Professor, Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota

Ming Yang, Ph.D., Director, Research, Graybug Vision

Mingjie Xie, MSc, MBA, Co-Founder and CEO, Rapid Novor, Inc.

Naj Sharif, Ph.D., FARVO, FBPhS, Executive Director; Head, Global Alliances & External Research, Santen, Inc.

Natalie Roy D’Amore, Ph.D., Director, Early Discovery Oncology, Takeda Pharmaceuticals

Nathanael Gray, Ph.D., Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Professor, Cancer Biology, Dana-Farber Cancer Institute

Nello Mainolfi, Ph.D., Senior Director, Head of Drug Discovery, Raze Therapeutics

Nelson Chau, Ph.D., Vice President, Drug Discovery, RaNA Therapeutics

Nicholas Cosford, Ph.D., Associate Director, Translational Research & Professor, Cancer Metabolism and Signaling Networks Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Nikole Kimes, Ph.D., Co-Founder and Vice President, Siolta Therapeutics

Omar Abudayyeh, M.D., Ph.D. Student, Harvard-MIT Health Sciences and Technology, Laboratory of Dr. Feng Zhang, Broad Institute of MIT and Harvard

Osamu Kurasawa, Ph.D., Principal Scientist, Medicinal Chemistry, Takeda Pharamaceutical Co. Ltd.

Pamela Chang, Ph.D., Assistant Professor, Department of Microbiology and Immunology, Cornell University

Pankaj B. Agrawal, M.D., MMSC, Geneticist and Medical Director, Gene Discovery Core, Manton Center for Orphan Disease Research, Boston Children’s Hospital; Assistant Professor, Pediatrics, Harvard Medical School

Partha Chowdhury, Ph.D., Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Pascal Egloff, Ph.D., Postdoctoral Researcher, Markus Seeger Group, Institute of Medical Microbiology, University of Zurich, Switzerland

Patrick Collins, Ph.D., Senior Scientist, Genome Analysis Unit, Amgen

Patrick Matthias, Ph.D., Senior Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI)

Patrick Y. Lu, Ph.D., President & CEO, Sirnaomics, Inc.

Paul Diehl, Ph.D., COO, Cellecta

Paul Trippier, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center

Paula M. Loria, Ph.D., Associate Research Fellow, Primary Pharmacology Group, Discovery Sciences, Pfizer

Pawel Sledz, Ph.D., Senior Research Associate, Department of Biochemistry, Caflisch Laboratory, University of Zurich

Peter Coombs, Ph.D., Senior Scientist, Assay Development & Screening Group, MRC Technology

Peter S. DiStefano, Ph.D., CSO, Zebra Biologics, Inc.

Peter Slivka, Ph.D., Senior Scientist, Foundational Immunology, AbbVie Bioresearch Center

Phillip Schwartz, Ph.D., Senior Scientist, Structural Biology and Biophysics, Takeda California

Pierre Raboisson, Ph.D., Head, IDV Europe Discovery, Janssen

R.P. (Kris) Iyer, Ph.D., Co-Founder & CSO, Spring Bank Pharmaceuticals

Raghu Pandurangi, Ph.D., Founder & President, Drug Design, Sci-Engi-Medco Solutions, Inc.

Rajiv Jalan, M.D., Ph.D., Professor of Hepatology, University College London

Ralph Mazitschek, Ph.D., Assistant Professor, Harvard Medical School; Co-Director of the Chemical Biology Platform, Center for Systems Biology, Massachusetts General Hospital

Ravi Amaravadi, M.D., Associate Professor, Medicine, University of Pennsylvania

Rebecca Taub, M.D., CMO & Executive Vice President, R&D, Madrigal Pharmaceuticals

Rene Rijnbrand, Ph.D., Vice President, Biology, Arbutus

Ricardo Mouro Pinto, Ph.D., Instructor in Neurology, Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School

Richard Colonno, Ph.D., CSO, Assembly Biosciences

Richard K. Harrison, Ph.D., CSO, Clarivate Analytics

Rick Beckman, M.D., CMO, Clearside Biomedical, Inc.

Robert H. Scannevin, Ph.D., Vice President, Discovery Biology, Yumanity Therapeutics

Robert Lowery, Ph.D., President & CEO, BellBrook Labs

Robert T. Foster, PharmD, Ph.D., CSO, ContraVir Pharmaceuticals Inc. and Professor, Pharmacy & Pharmaceutical Sciences, University of Alberta, Canada

Robert Vassar, Ph.D., Professor, Cell and Molecular Biology, The Feinberg School of Medicine, Northwestern University

Roderick Beijersbergen, Ph.D., Group Leader, Netherlands Cancer Institute and Head, NKI Robotics and Screening Center

Rodolphe Clerval, Chief Business Officer, Vice President US Operations, Enterome Bioscience

Roland Grenningloh, Ph.D., Director, Preclinical Pharmacology, EMD Serono

Ronald Alfa, M.D., Ph.D., Vice President, Discovery & Product, Recursion Pharmaceuticals

Ronald Swanson, Ph.D., Senior Director, Janssen

Ronnie Wei, Ph.D., Senior Principal Scientist, Sanofi-Genzyme

Roshan Kumar, Cambridge Site Head, HiFiBiO, Inc.

Ross Bathgate, Ph.D., Head, Neuropeptides Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne

Ryan Hartmaier, Ph.D., Senior Scientist, Cancer Genomics, Foundation Medicine, Inc.

S. Pablo Sardi, Ph.D., Pharm.D., R&D Director, Neuroscience, Sanofi

Samuel Gunderson, Ph.D., President and Co-Founder, SilaGene Inc.

Sarah A. Cooley, M.D., Associate Professor, Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota

Sarah L. DeVos, Ph.D., Postdoctoral Fellow, Laboratory of Dr. Bradley T Hyman, Massachusetts General Hospital

Scott Ellis, Ph.D., Head, Early Development, Oxford BioMedica

Scott Jackson, Ph.D., Molecular Genetics and Microbial Genomics, National Institute of Standards and Technology

Scott R. Prosser, Ph.D., Professor, Chemistry and Biochemistry, University of Toronto, Canada

Ségolène Aymé, Emeritus Director of Research, French Institute of Health and Medical Research (INSERM); Expert in Residence for Rare Diseases, Brain and Spine Institute, Paris; and Editor-in-Chief, Orphanet Journal of Rare Diseases

Sergey Ovchinnikov, Biologist, Baker Lab, Institute for Protein Design, University of Washington

Shanthi Ganesh, Ph.D., Associate Director, Pre Clinical Oncology, Dicerna Pharmaceuticals, Inc.

Shaomeng Wang, Ph.D., Warner-Lambert/Parke-Davis Professor, Medicine; Professor, Medicine, Pharmacology and Medicinal Chemistry; Director, Center for Therapeutics Innovation, University of Michigan

Sharon Klier, Vice President, Ophthalmology, Medical, Quark Pharmaceuticals

Shaun M. McLoughlin, Ph.D., Senior Research Scientist III, Target Identification and Validation Technologies, AbbVie

Shenping Liu, Ph.D., Associate Research Fellow, Discovery Sciences Groton, Pfizer

Sid Topiol, Ph.D., CSO, 3D-2drug, LLC; Professor and Director, Structural and Computational Drug Discovery, Stevens Institute of Technology

Simone Treiger Sredni, M.D., Ph.D., Associate Professor of Pediatric Neurosurgery, Ann and Robert H. Lurie Children’s Hospital of Chicago and Northwestern University, Feinberg School of Medicine

Songqing Na, Ph.D., Senior Scientist, Biotechnology & Autoimmunity Res-AME, Eli Lilly and Company

Sophie Lelièvre, D.V.M., LLM, Ph.D., Professor, Department of Basic Medical Sciences; Associate Director, Collaborative Science, NCI-Designated Purdue Center for Cancer Research, Purdue University

Sriram Subramaniam, Ph.D., Senior Investigator, Head, Biophysics Section, Laboratory of Cell Biology, National Institutes of Health

Stefan Knapp, Ph.D., Professor, Department of Pharmaceutical Chemistry, Goethe Institut, Frankfurt

Stefan M. Pulst, M.D., Professor and Chair, Department of Neurology, University of Utah

Steffen Weinbrenner, Ph.D., Head Drug Discovery, Drug Discovery, Polyphor Ltd

Stephan Urban, Ph.D., Professor, Department of Infectious Diseases, Translational Virology, University Hospital Heidelberg

Stephane Perreault, Ph.D., Research Scientist II, Medicinal Chemistry, Gilead Sciences, Inc.

Stephanie Mohr, Ph.D., Lecturer, Genetics & Director, Drosophila RNAi Screening Center at Harvard Medical School

Stephanos Ioannidis, Ph.D., Head, Early Portfolio, FORMA Therapeutics

Stephen G. Sligar, Ph.D., Swanlund Chair and Director, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign

Stephen Shuttleworth, Ph.D., COO and CSO, Karus Therapeutics Ltd.

Sudeep Basu, Ph.D., Practice Leader, TechVision-Innovation Services, Frost & Sullivan

Sungyoo Cho, Ph.D., CSO, Green Cross LabCell

Susanne Saalau, Ph.D., Director, Molecular Science, Astex Pharmaceuticals

Suzanne Hibbs, MS, MBA, Study Coordination Manager, Cell Design Studio, MilliporeSigma

Svetlana Hamm, Ph.D., Head of Translational Pharmacology, 4SC AG

Tania Konry, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University

Tatiana Ort, Ph.D., Director, Immunology Research, Janssen Research & Development

Tauseef R. Butt, Ph.D., President and CEO, Progenra, Inc.

Thomas D. Madden, Ph.D., President and CEO, Acuitas Therapeutics

Thomas P. Sakmar, M.D., Richard M. & Isabel P. Furlaud Professor, Laboratory of Chemical Biology & Signal Transduction, The Rockefeller University; Guest Professor, Karolinska Institute, Sweden

Thomas Sundberg, Ph.D., Senior Research Scientist I, Center for Development of Therapeutics, Broad Institute of MIT and Harvard

Tillmann Michels, Ph.D., Head of Research Group Immune Checkpoint Inhibitors, Laboratory of Prof. Philipp Beckhove, Regensburg Center for Interventional Immunology

Tim Dafforn, Ph.D., Professor, Biotechnology, University of Birmingham, United Kingdom

Tim Kaminski, Ph.D., Postdoctoral Fellow, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca Gothenburg

Timothy A. McKinsey, Ph.D., Associate Professor and Associate Division Head for Translational Research, Director, Consortium for Fibrosis Research and Translation, Department of Medicine, Division of Cardiology, University of Colorado Denver

Timothy A. McKinsey, Ph.D., Director, Consortium for Fibrosis Research & Translation, Department of Medicine, University of Colorado – Anschutz Medical Campus

Timothy Shiau, Ph.D., Senior Scientist, Chemistry, Verseon

Tina Hieken, M.D., Surgical Oncologist and Associate Professor of Surgery, Mayo Clinic College of Medicine

Todd A. Fehniger, M.D., Ph.D., Associate Professor, Medicine, Division of Oncology, Washington University School of Medicine

Travis W. Bainbridge, MS, Senior Scientific Researcher, Department of Protein Chemistry, Genentech, Inc.

Trevor Perrior, Ph.D., CSO, Domainex

Trevor Wilkinson, Ph.D., Associate Director, Antibody Discovery and Protein Engineering, MedImmune Ltd., United Kingdom

Varun Prabhu, Ph.D., Associate Director, Research & Development, Oncoceutics, Inc.

Vicky Steadman, Ph.D., Director of Drug Discovery, Cypralis

Vlad Denic, Ph.D., Professor, Molecular and Cellular Biology, Harvard University

Wayne W. Hancock, M.D., Ph.D., Professor of Pathology and Chief of Transplant Immunology, Children’s Hospital of Philadelphia and University of Pennsylvania

Wayne Matson, Ph.D., Chief Scientist & Co-Founder, Research & Development, Ixcela, Inc.

Weilin Xie, Ph.D., Senior Principal Scientist, Biotherapeutics, Celgene

Weiwen Ying, Ph.D., Co-Founder and President, Drug Discovery, Capten Therapeutics

William Loging, Ph.D., Associate Professor of Genomics & Head, Production Bioinformatics, Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai; Editor, Bioinformatics and Computational Biology in Drug Discovery and Development

William Loging, Ph.D., Associate Professor of Genomics & Head, Production Bioinformatics, Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai; Editor, Bioinformatics and Computational Biology in Drug Discovery and Development, Cambridge University Press, 2016

Xiao Zhen Zhou, Ph.D., Assistant Professor, Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School

Xiaole Shirley Liu, Ph.D., Professor, Department of Biostatistics and Computational Biology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard School of Public Health

Xiaomin Chen, Ph.D., Senior Principal Scientist, Structural & Molecular Sciences, Worldwide Research & Development, Pfizer

Xin Lu, Ph.D., John M. and Mary Jo Boler Assistant Professor, Department of Biological Sciences, Center for Rare and Neglected Diseases, Harper Cancer Research Institute, University of Notre Dame

Yat Sun Or, Ph.D., Senior Vice President, R&D and CSO, Enanta Pharmaceuticals, Inc.

Ying Luo, Ph.D., CEO, GNI Group

Ying-Xian Pan, M.D., Ph.D., Laboratory Head, Department of Neurology, Memorial Sloan Kettering Cancer Center

Yuzhen Ye, Ph.D., Associate Professor, Computer Science, Indiana University, Bloomington

Zain Kassam, M.D., MPH, FRCPC, CMO, OpenBiome; Gastroenterologist, Epidemiologist and Research Affiliate, MIT Center for Microbiome Informatics & Therapeutics

Zaven Kaprielian, Ph.D., Director, Neuroscience Research, Amgen

Zhengrong Zhu, Ph.D., Scientific Leader, PTS-DDS-NCE, GlaxoSmithKline